These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1094642)

  • 1. The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts.
    Tremann JA; Haines JG; Bleifuss JH; Agodoa LC; Marchioro TL
    Transplantation; 1975 Jun; 19(6):520-2. PubMed ID: 1094642
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Steroids and cyclophosphamide dosage in renal allograft perfusion.
    Woods JE; Zincke H
    Transplantation; 1976 Mar; 21(3):260. PubMed ID: 781925
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effect of high-dose steroids on renal autografts and homografts.
    Tremann JA; Agodoa LC; Cooper TP; Striker GE; Marchioro TL
    Surgery; 1976 Apr; 79(4):370-6. PubMed ID: 769217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits of methylprednisolone in the isolated perfused organ.
    Starling JR; Rudolf LE; Ferguson W; Wangensteen SL
    Ann Surg; 1973 May; 177(5):566-71. PubMed ID: 4574226
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of the protective effect of methylprednisolone, furosemide, and mannitol on ischemically damaged kidneys.
    Toledo-Pereyra LH; Ramakrishnan VR; Zammit M
    Eur Surg Res; 1979; 11(3):179-84. PubMed ID: 389634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-day perfusion of canine kidneys: a postulated effect of steroids.
    Woods JE; Fleisher GA; Hirsche BL
    Transplant Proc; 1974 Sep; 6(3):255-60. PubMed ID: 4153357
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylprednisolone, glucagon, and allopurinol in the protection of pancreaticoduodenal allografts perfused for twenty-four hours.
    Tersigni R; Toledo-Pereyra LH; Najarian JS
    Surgery; 1975 Nov; 78(5):599-607. PubMed ID: 1103338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pharmacological doses of methylprednisolone on preservation of renal function.
    Rashid HA; Panner BJ; Linke CA
    J Surg Res; 1975 Jan; 18(1):21-8. PubMed ID: 1117712
    [No Abstract]   [Full Text] [Related]  

  • 20. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.